CoChat

Inhibition of nuclear Wnt signalling: challenges of an elusive target for cancer therapy

Open access
Lyou, Yung, Habowski, Amber N, Chen, George T, Waterman, Marian L · 2017 · British Journal of Pharmacology
Cited by 58

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

The highly conserved Wnt signalling pathway plays an important role in embryonic development and disease pathogenesis, most notably cancer. The ‘canonical’ or β‐catenin‐dependent Wnt signal initiates at the cell plasma membrane with the binding of Wnt proteins to Frizzled:LRP5/LRP6 receptor complexes and is mediated by the translocation of the transcription co‐activator protein, β‐catenin, into the nucleus. β‐Catenin then forms a complex with T‐cell factor (TCF)/lymphoid enhancer binding factor (LEF) transcription factors to regulate multiple gene programmes. These programmes play roles in cell proliferation, migration, vasculogenesis, survival and metabolism. Mutations in Wnt signalling pathway components lead to constitutively active Wnt signalling that drives aberrant expression of these programmes and development of cancer. It has been a longstanding and challenging goal to develop therapies that can interfere with the TCF/LEF–β‐catenin transcriptional complex. This review will focus on the (i) structural considerations for targeting the TCF/LEF–β‐catenin and co‐regulatory complexes in the nucleus, (ii) current molecules that directly target TCF/LEF–β‐catenin activity and (iii) ideas for targeting newly discovered components of the TCF/LEF–β‐catenin complex and/or downstream gene programmes regulated by these complexes. Linked Articles: This article is part of a themed section on WNT Signalling: Mechanisms and Therapeutic Opportunities. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.24/issuetoc

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bph.13963

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 58

Metadata

Authors
Lyou, Y., Habowski, A. N., Chen, G. T., & Waterman, M. L.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2017-08-24
Volume
174
Issue
24
Pages
4589-4599
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2741047383
Cited by
58
References
15
FWCI
2.72
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibition of nuclear Wnt signalling: challenges of an elusive target for cancer therapy. https://app.cochat.ai/papers/10.1111/bph.13963
The paper
Lyou, Y., Habowski, A. N., Chen, G. T., & Waterman, M. L. (2017). Inhibition of nuclear Wnt signalling: challenges of an elusive target for cancer therapy. British Journal of Pharmacology. https://doi.org/10.1111/bph.13963

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.